Healthcare New Highs: UnitedHealth Group Inc. (NYSE:UNH), WellPoint Inc (NYSE:WLP), Insulet Corporation (NASDAQ:PODD), Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI)

UnitedHealth Group (NYSE:UNH) rose 7.45% last week, as health-care providers are starting to see increased membership, thanks to the Affordable Care Act. UnitedHealth competitor WellPoint, in particular, increased its full-year guidance this past week and expects more than 1 million new health plan members this year. UnitedHealth Group Inc. (NYSE:UNH) stock performance was -0.23% in last session and finished the day at $81.34. Traded volume … Continue reading Healthcare New Highs: UnitedHealth Group Inc. (NYSE:UNH), WellPoint Inc (NYSE:WLP), Insulet Corporation (NASDAQ:PODD), Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI)

Healthcare Bullish Stocks: Biota Pharmaceuticals (NASDAQ:BOTA), OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI), Vermillion (NASDAQ:VRML), Genetic Technologies (NASDAQ:GENE)

Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) presented an update on the company at the 26th Annual ROTH Conference at 12:30 p.m. PDT, March 11, 2014, at The Ritz-Carlton, Dana Point in California. Biota Pharmaceuticals Inc (NASDAQ:BOTA) stock performance was 10.15% in last session and finished the day at $6.62. Traded volume was 449,674 million shares in the last session and the average volume of the stock remained … Continue reading Healthcare Bullish Stocks: Biota Pharmaceuticals (NASDAQ:BOTA), OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI), Vermillion (NASDAQ:VRML), Genetic Technologies (NASDAQ:GENE)

U.S. health regulators on Friday approved a Celgene Corporation (NASDAQ:CELG) drug to treat psoriatic arthritis, a type of arthritis associated with the skin disease psoriasis that causes joint pain, stiffness and swelling. Celgene Corporation (NASDAQ:CELG) stock performance was -3.74% in last session and finished the day at $144.40. Traded volume was 9.50million shares in the last session and the average volume of the stock remained … Continue reading Biotech Active Stocks: Celgene Corporation (NASDAQ:CELG), Arena Pharmaceuticals (NASDAQ:ARNA), Cell Therapeutics (NASDAQ:CTIC), Inovio Pharmaceuticals (NYSEMKT:INO)

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and AstraZeneca (NYSE:AZN) are among those companies with late stage drugs in trials that specifically target genetic mutations. Both BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)’s BMN-673, which is in phase 3 trials, and Astra’s Olaparib, which may get the EU’s go-ahead in ovarian cancer this year, address a mutation of the BRCA 1 and BRCA 2 gene that is often associated with breast … Continue reading Biotech Losers: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Novavax, Inc. (NASDAQ:NVAX), Biogen Idec Inc (NASDAQ:BIIB)

Cessna Aircraft Company, part of the Textron Aviation segment of Textron Inc. (NYSE:TXT), announced today a new aircraft to add to the company’s popular line of Cessna CJ-series jets. The new CJ3+ from Cessna includes a state-of-the-art fully integrated Garmin G3000™ avionics suite, all-new interiors with a redesigned cabin and cockpit, new pressurization, and new diagnostics systems. Textron Inc. (NYSE:TXT) stock performance was -0.16% in … Continue reading Aerospace Stocks: Textron Inc. (NYSE:TXT), Northrop Grumman Corporation (NYSE:NOC), Gencorp Inc (NYSE:GY), Micronet Enertec Technologies (NASDAQ:MICT)

Johnson & Johnson (NYSE:JNJ) is an undisputed global leader in the health care industry, benefiting from a rock-solid competitive position in areas such as medical devices and several pharmaceutical markets. Growing health care demand due to an aging population, broadened health insurance coverage, and technological advancements in the industry bode well for Johnson & Johnson (NYSE:JNJ) for years to come. Johnson & Johnson (NYSE:JNJ) stock … Continue reading Mega Cap Most Active: Johnson & Johnson (NYSE:JNJ), Apple Inc. (NASDAQ:AAPL), International Business Machines (NYSE:IBM), Microsoft Corporation (NASDAQ:MSFT)